SeqOne is a clinical genomics company founded in 2017. It provides molecular laboratories with an AI-powered next-generation sequencing (NGS) platform and accompanying expert services, intended to help them turn genomic data into clinical answers faster, with particular support for variant interpretation and clinical reporting. The work sits at the intersection of next-generation sequencing, machine learning and genomic data analysis, applied to regulated clinical diagnostics.
The platform is used in over 35 countries by public and private laboratories and national genomic programmes. Its applications span rare and inherited diseases, oncology, preventive genomics, infectious diseases and molecular diagnostics more broadly. The company holds IVDR certification, and its model combines automated analysis with expert human services rather than relying on software alone.
SeqOne describes its mission as making personalised medicine a reality for every patient. Its stated approach pairs AI technology with specialist review, and it positions itself as a fast-growing company operating across international markets.
